{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:54:13Z","timestamp":1775570053764,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002597","name":"Kyung Hee University","doi-asserted-by":"publisher","award":["GS-1-JO-ON-20241905"],"award-info":[{"award-number":["GS-1-JO-ON-20241905"]}],"id":[{"id":"10.13039\/501100002597","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11776-0","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:34:06Z","timestamp":1775561646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ZPT01, a herbal formula of Zingiberis Rhizoma, Paeoniae Radix and Tribuli Fructus, protects dopaminergic neurons and suppresses neuroinflammation in a Parkinson\u2019s disease model"],"prefix":"10.1007","volume":"53","author":[{"given":"Jin Hee","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Sook","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"1","key":"11776_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41531-024-00781-4","volume":"10","author":"S Chevalier","year":"2024","unstructured":"Chevalier S, Decourt M, Francheteau M, Nicol F, Balbous A, Fernagut PO, Benoit-Marand M (2024) Alpha-synuclein-induced nigrostriatal degeneration and pramipexole treatment disrupt frontostriatal plasticity. NPJ Parkinsons Dis 10(1):169","journal-title":"NPJ Parkinsons Dis"},{"key":"11776_CR2","doi-asserted-by":"publisher","first-page":"114645","DOI":"10.1016\/j.expneurol.2023.114645","volume":"373","author":"K Rademacher","year":"2024","unstructured":"Rademacher K, Nakamura K (2024) Role of dopamine neuron activity in Parkinson\u2019s disease pathophysiology. Exp Neurol 373:114645","journal-title":"Exp Neurol"},{"issue":"1","key":"11776_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41531-023-00535-8","volume":"9","author":"AC Muller-Nedebock","year":"2023","unstructured":"Muller-Nedebock AC, Dekker MCJ, Farrer MJ, Hattori N, Lim SY, Mellick GD, Rektorova I, Salama M, Schuh AFS, Stoessl AJ, Sue CM, Tan AH, Vidal RL, Klein C, Bardien S (2023) Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson\u2019s disease. NPJ Parkinsons Dis 9(1):110","journal-title":"NPJ Parkinsons Dis"},{"key":"11776_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-genom-082410-101440","volume":"12","author":"I Martin","year":"2011","unstructured":"Martin I, Dawson VL, Dawson TM (2011) Recent advances in the genetics of Parkinson\u2019s disease. Annu Rev Genomics Hum Genet 12:301\u2013325","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"11776_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106\u2013107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol 106\u2013107:17\u201332","journal-title":"Prog Neurobiol"},{"issue":"1","key":"11776_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.apsb.2024.10.004","volume":"15","author":"UC Dash","year":"2025","unstructured":"Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V, Panda SK, Kerry RG, Duttaroy AK, Jena AB (2025) Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications. Acta Pharm Sin B 15(1):15\u201334","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"11776_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/15548627.2015.1071759","volume":"12","author":"RT Netea-Maier","year":"2016","unstructured":"Netea-Maier RT, Plantinga TS, van de Veerdonk FL, Smit JW, Netea MG (2016) Modulation of inflammation by autophagy: Consequences for human disease. Autophagy 12(2):245\u2013260","journal-title":"Autophagy"},{"issue":"1","key":"11776_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8(1):73","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"11776_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3988\/jcn.2022.18.3.259","volume":"18","author":"HW Shin","year":"2022","unstructured":"Shin HW, Hong SW, Youn YC (2022) Clinical Aspects of the Differential Diagnosis of Parkinson\u2019s Disease and Parkinsonism. J Clin Neurol 18(3):259\u2013270","journal-title":"J Clin Neurol"},{"issue":"1","key":"11776_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7(1):47","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"11776_CR11","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/aje\/kwv271","volume":"183","author":"SK Darweesh","year":"2016","unstructured":"Darweesh SK, Koudstaal PJ, Stricker BH, Hofman A, Ikram MA (2016) Trends in the Incidence of Parkinson Disease in the General Population: The Rotterdam Study. Am J Epidemiol 183(11):1018\u20131026","journal-title":"Am J Epidemiol"},{"key":"11776_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnbeh.2016.00121","volume":"10","author":"D Ferrazzoli","year":"2016","unstructured":"Ferrazzoli D, Carter A, Ustun FS, Palamara G, Ortelli P, Maestri R, Yucel M, Frazzitta G (2016) Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson\u2019s Disease: Implications for Rehabilitation. Front Behav Neurosci 10:121","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"11776_CR13","doi-asserted-by":"publisher","first-page":"7847","DOI":"10.1038\/s41598-025-91344-x","volume":"15","author":"QH Xu","year":"2025","unstructured":"Xu QH, Wang YL, Wang C, Jiang SS, Zhang BR, Tian J (2025) Exploring the active ingredients and potential mechanisms of Pingchan granules in Parkinson\u2019s disease treatment through network pharmacology and transcriptomics. Sci Rep 15(1):7847","journal-title":"Sci Rep"},{"issue":"1","key":"11776_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41531-022-00307-w","volume":"8","author":"SL Farrow","year":"2022","unstructured":"Farrow SL, Cooper AA, O\u2019Sullivan JM (2022) Redefining the hypotheses driving Parkinson\u2019s diseases research. NPJ Parkinsons Dis 8(1):45","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"11776_CR15","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.2174\/156802612801319034","volume":"12","author":"Y Wang","year":"2012","unstructured":"Wang Y, Fan X, Qu H, Gao X, Cheng Y (2012) Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine. Curr Top Med Chem 12(12):1356\u20131362","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"11776_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.pbb.2005.09.004","volume":"82","author":"X Li","year":"2005","unstructured":"Li X, Matsumoto K, Murakami Y, Tezuka Y, Wu Y, Kadota S (2005) Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice. Pharmacol Biochem Behav 82(2):345\u2013352","journal-title":"Pharmacol Biochem Behav"},{"issue":"S 1","key":"11776_CR17","first-page":"89","volume":"36","author":"K Chandrasekaran","year":"2003","unstructured":"Chandrasekaran K, Mehrabian Z, Spinnewyn B, Chinopoulos C, Drieu K, Fiskum G (2003) Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761\u00ae) in global brain ischemia and in excitotoxicity-induced neuronal death. Pharmacopsychiatry 36(S 1):89\u201394","journal-title":"Pharmacopsychiatry"},{"key":"11776_CR18","doi-asserted-by":"publisher","first-page":"775034","DOI":"10.3389\/fphar.2021.775034","volume":"12","author":"A Nowak","year":"2021","unstructured":"Nowak A, Kojder K, Zielonka-Brzezicka J, Wrobel J, Bosiacki M, Fabianska M, Wrobel M, Solek-Pastuszka J, Klimowicz A (2021) The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer\u2019s Disease. Front Pharmacol 12:775034","journal-title":"Front Pharmacol"},{"key":"11776_CR19","doi-asserted-by":"publisher","first-page":"109184","DOI":"10.1016\/j.biopha.2019.109184","volume":"117","author":"H Eo","year":"2019","unstructured":"Eo H, Kwon Y, Huh E, Sim Y, Choi JG, Jeong JS, Du XF, Soh HY, Hong SP, Kim Y, Pak MS, Oh (2019) Protective effects of DA-9805 on dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity in the models of Parkinson\u2019s disease. Biomed Pharmacother 117:109184","journal-title":"Biomed Pharmacother"},{"issue":"21","key":"11776_CR20","doi-asserted-by":"publisher","first-page":"10690","DOI":"10.1039\/D1FO01403J","volume":"12","author":"IG Ju","year":"2021","unstructured":"Ju IG, Hong SM, Yun SW, Huh E, Kim DH, Kim SY, Oh MS (2021) CCL01, a novel formulation composed of Cuscuta seeds and Lactobacillus paracasei NK112, enhances memory function via nerve growth factor-mediated neurogenesis. Food Funct 12(21):10690\u201310699","journal-title":"Food Funct"},{"issue":"6","key":"11776_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/1028415X.2018.1520477","volume":"23","author":"E Huh","year":"2020","unstructured":"Huh E, Choi JG, Noh D, Yoo HS, Ryu J, Kim NJ, Kim H, Oh MS (2020) Ginger and 6-shogaol protect intestinal tight junction and enteric dopaminergic neurons against 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine in mice. Nutr Neurosci 23(6):455\u2013464","journal-title":"Nutr Neurosci"},{"issue":"4","key":"11776_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4062\/biomolther.2023.098","volume":"31","author":"E Huh","year":"2023","unstructured":"Huh E, Choi JG, Choi Y, Ju IG, Noh D, Shin DY, Kim DH, Park HJ, Oh MS (2023) 6-Shogaol, an Active Ingredient of Ginger, Improves Intestinal and Brain Abnormalities in Proteus Mirabilis-Induced Parkinson\u2019s Disease Mouse Model. Biomol Ther (Seoul) 31(4):417\u2013424","journal-title":"Biomol Ther (Seoul)"},{"issue":"5","key":"11776_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4062\/biomolther.2024.075","volume":"32","author":"JH Kim","year":"2024","unstructured":"Kim JH, Kim JS, Ju IG, Huh E, Choi Y, Lee S, Cho JY, Park BY, Oh MS (2024) Coadministration of 6-Shogaol and Levodopa Alleviates Parkinson\u2019s Disease-Related Pathology in Mice. Biomol Ther (Seoul) 32(5):523\u2013530","journal-title":"Biomol Ther (Seoul)"},{"key":"11776_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12906-016-1205-y","volume":"16","author":"G Lee","year":"2016","unstructured":"Lee G, Joo JC, Choi BY, Lindroth AM, Park SJ, Park YJ (2016) Neuroprotective effects of Paeonia Lactiflora extract against cell death of dopaminergic SH-SY5Y cells is mediated by epigenetic modulation. BMC Complement Altern Med 16:208","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"11776_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11011-025-01764-x","volume":"41","author":"Y Choi","year":"2025","unstructured":"Choi Y, Huh E, Ju IG, Lee H, Kim JH, Lee S, Park S, Choi M, Jang YP, Park HJ, Oh MS (2025) Paeony root prevents 6-hydroxydopamine-induced neurotoxicity by regulating autophagic dysfunction via AKT signaling in Parkinson's disease models. Metab Brain Dis 41(1):11","journal-title":"Metab Brain Dis"},{"issue":"1","key":"11776_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11011-024-01498-2","volume":"40","author":"JH Kim","year":"2024","unstructured":"Kim JH, Huh E, Eo H, Kim JS, Kwon Y, Ju IG, Choi Y, Yoon HJ, Son SR, Jang DS, Hong SP, Park HJ, Oh MS (2024) Tribuli Fructus alleviates 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson\u2019s disease by suppressing neuroinflammation via JNK signaling. Metab Brain Dis 40(1):69","journal-title":"Metab Brain Dis"},{"issue":"10","key":"11776_CR27","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jnutbio.2014.05.009","volume":"25","author":"S Lim","year":"2014","unstructured":"Lim S, Moon M, Oh H, Kim HG, Kim SY, Oh MS (2014) Ginger improves cognitive function via NGF-induced ERK\/CREB activation in the hippocampus of the mouse. J Nutr Biochem 25(10):1058\u20131065","journal-title":"J Nutr Biochem"},{"issue":"1","key":"11776_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11011-025-01764-x","volume":"41","author":"Y Choi","year":"2025","unstructured":"Choi Y, Huh E, Ju IG, Lee H, Kim JH, Lee S, Park S, Choi M, Jang YP, Park HJ, Oh MS (2025) Paeony root prevents 6-hydroxydopamine-induced neurotoxicity by regulating autophagic dysfunction via AKT signaling in Parkinson\u2019s disease models. Metab Brain Dis 41(1):11","journal-title":"Metab Brain Dis"},{"key":"11776_CR29","doi-asserted-by":"publisher","first-page":"104846","DOI":"10.1016\/j.yexmp.2022.104846","volume":"129","author":"A Goyal","year":"2023","unstructured":"Goyal A, Agrawal A, Verma A, Dubey N (2023) The PI3K-AKT pathway: A plausible therapeutic target in Parkinson\u2019s disease. Exp Mol Pathol 129:104846","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"11776_CR30","doi-asserted-by":"publisher","first-page":"9459","DOI":"10.1038\/s41598-017-09528-z","volume":"7","author":"X Kang","year":"2017","unstructured":"Kang X, Qiu J, Li Q, Bell KA, Du Y, Jung DW, Lee JY, Hao J, Jiang J (2017) Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype. Sci Rep 7(1):9459","journal-title":"Sci Rep"},{"issue":"6","key":"11776_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/biof.1035","volume":"38","author":"P Teismann","year":"2012","unstructured":"Teismann P (2012) COX-2 in the neurodegenerative process of Parkinson\u2019s disease. BioFactors 38(6):395\u2013397","journal-title":"BioFactors"},{"issue":"1","key":"11776_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.14336\/AD.2021.0729","volume":"13","author":"X Xie","year":"2022","unstructured":"Xie X, Shu R, Yu C, Fu Z, Li Z (2022) Mammalian AKT, the Emerging Roles on Mitochondrial Function in Diseases. Aging Dis 13(1):157\u2013174","journal-title":"Aging Dis"},{"issue":"3","key":"11776_CR33","first-page":"381","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A, Signaling AKTPKB (2017) Navigating Netw Cell 169(3):381\u2013405","journal-title":"Navigating Netw Cell"},{"issue":"1","key":"11776_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0969-9961(03)00013-5","volume":"14","author":"KL O\u2019Malley","year":"2003","unstructured":"O\u2019Malley KL, Liu J, Lotharius J, Holtz W (2003) Targeted expression of BCL-2 attenuates MPP\u2009+\u2009but not 6-OHDA induced cell death in dopaminergic neurons. Neurobiol Dis 14(1):43\u201351","journal-title":"Neurobiol Dis"},{"key":"11776_CR35","doi-asserted-by":"publisher","first-page":"113568","DOI":"10.1016\/j.jep.2020.113568","volume":"268","author":"M Zheng","year":"2021","unstructured":"Zheng M, Chen M, Wang W, Zhou M, Liu C, Fan Y, Shi D (2021) Protection by rhynchophylline against MPTP\/MPP(+)-induced neurotoxicity via regulating PI3K\/Akt pathway. J Ethnopharmacol 268:113568","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"11776_CR36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0090-6980(97)00128-7","volume":"54","author":"WE Kaufmann","year":"1997","unstructured":"Kaufmann WE, Andreasson KI, Isakson PC, Worley PF (1997) Cyclooxygenases and the central nervous system. Prostaglandins 54(3):601\u2013624","journal-title":"Prostaglandins"},{"key":"11776_CR37","doi-asserted-by":"publisher","first-page":"815347","DOI":"10.3389\/fnagi.2022.815347","volume":"14","author":"S Guo","year":"2022","unstructured":"Guo S, Wang H, Yin Y (2022) Microglia Polarization From M1 to M2 in Neurodegenerative Diseases. Front Aging Neurosci 14:815347","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"11776_CR38","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1111\/j.0953-816X.2004.03441.x","volume":"19","author":"KM Lee","year":"2004","unstructured":"Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, Park JS, Cho HJ (2004) Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci 19(12):3375\u20133381","journal-title":"Eur J Neurosci"},{"issue":"8","key":"11776_CR39","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1007\/s00210-024-03027-5","volume":"397","author":"B Sarkar","year":"2024","unstructured":"Sarkar B, Rana N, Singh C, Singh A (2024) Medicinal herbal remedies in neurodegenerative diseases: an update on antioxidant potential. Naunyn Schmiedebergs Arch Pharmacol 397(8):5483\u20135511","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"11776_CR40","doi-asserted-by":"publisher","first-page":"155101","DOI":"10.1016\/j.phymed.2023.155101","volume":"121","author":"D Cui","year":"2023","unstructured":"Cui D, Chen Y, Ye B, Guo W, Wang D, He J (2023) Natural products for the treatment of neurodegenerative diseases. Phytomedicine 121:155101","journal-title":"Phytomedicine"},{"issue":"3","key":"11776_CR41","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3390\/ijms27031301","volume":"27","author":"X Wu","year":"2026","unstructured":"Wu X, Zhang L, Luo S, Li Q, Wang J, Chen W, Zhou N, Zhou L, Li R, Xie Y, Chen Q (2026) Natural Neurobiological Active Compounds in Parkinson\u2019s Disease: Molecular Targets, Signaling Pathways, and Therapeutic Prospects. Int J Mol Sci 27(3):1301","journal-title":"Int J Mol Sci"},{"issue":"6","key":"11776_CR42","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/ph18060831","volume":"18","author":"EE Katsoulaki","year":"2025","unstructured":"Katsoulaki EE, Dimopoulos D, Hadjipavlou-Litina D (2025) Multitarget compounds designed for Alzheimer, Parkinson, and Huntington neurodegeneration diseases. Pharmaceuticals 18(6):831","journal-title":"Pharmaceuticals"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11776-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11776-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11776-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:02:33Z","timestamp":1775566953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11776-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11776"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11776-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"594"}}